J
Julie Bastien
Researcher at Novartis
Publications - 5
Citations - 572
Julie Bastien is an academic researcher from Novartis. The author has contributed to research in topics: Autophagy & Human mitochondrial genetics. The author has an hindex of 3, co-authored 5 publications receiving 395 citations.
Papers
More filters
Journal ArticleDOI
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo
William E. Dowdle,Beat Nyfeler,Jane Nagel,Robert Elling,Shanming Liu,Ellen Triantafellow,Suchithra Menon,Zuncai Wang,Ayako Honda,Gwynn Pardee,John Cantwell,Catherine Luu,Ivan Cornella-Taracido,Edmund Harrington,Peter Fekkes,Hong Lei,Qing Fang,Mary Ellen Digan,Debra Burdick,Andrew F. Powers,Stephen B. Helliwell,Simon D’Aquin,Julie Bastien,Henry Wang,Dmitri Wiederschain,Jenny Kuerth,Philip Bergman,David Schwalb,Jason R. Thomas,Savuth Ugwonali,Fred Harbinski,John A. Tallarico,Christine D. Wilson,Vic E. Myer,Jeffery A. Porter,Dirksen E. Bussiere,Peter Finan,Mark Labow,Xiaohong Mao,Lawrence G. Hamann,Brendan D. Manning,Reginald Valdez,Thomas B. Nicholson,Markus Schirle,Mark Knapp,Erin P. Keaney,Leon Murphy +46 more
TL;DR: a4−/− mice exhibit a profound accumulation of iron in splenic macrophages, which are critical for the reutilization of iron from engulfed red blood cells, and a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo is revealed.
Journal ArticleDOI
Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo
Oliver M. Russell,Isabelle Fruh,Pavandeep K. Rai,David Marcellin,Thierry Doll,Amy K. Reeve,Mitchel Germain,Julie Bastien,Karolina A. Rygiel,Raffaele Cerino,Andreas W. Sailer,Majlinda Lako,Robert W. Taylor,Matthias Mueller,Robert N. Lightowlers,Douglass M. Turnbull,Stephen B. Helliwell +16 more
TL;DR: During human stem cell division, cells not only tolerate high mtDNA deletion loads but seem to preferentially replicate deleted mtDNA genomes, which has implications for the involvement of mtDNA deletions in both disease and ageing.
Journal ArticleDOI
Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis.
Zhong-Yi Wang,Adrian Keogh,Annick Waldt,Rachel Cuttat,Marilisa Neri,Shanshan Zhu,Sven Schuierer,Alexandra Ruchti,Christophe Crochemore,Judith Knehr,Julie Bastien,Iwona Ksiazek,Daniel Sánchez-Taltavull,Hui Ge,Jing Wu,Guglielmo Roma,Stephen B. Helliwell,Deborah Stroka,Florian Nigsch +18 more
TL;DR: In this article, the authors identify 61 liver fibrosis-associated genes (e.g., AEBP1, PRRX1 and LARP6) that may serve as a repertoire of translatable drug target candidates.
Journal ArticleDOI
Stendomycin selectively inhibits TIM23-dependent mitochondrial protein import
Ireos Filipuzzi,Janos Steffen,Mitchel Germain,Laetitia Goepfert,Michael A. Conti,Christoph Potting,Raffaele Cerino,Martin Pfeifer,Philipp Krastel,Dominic Hoepfner,Julie Bastien,Carla M. Koehler,Stephen B. Helliwell +12 more
TL;DR: It is shown that the natural product stendomycin, produced by Streptomyces hygroscopicus, is a potent and specific inhibitor of the TIM23 complex in yeast and mammalian cells and that TIM23 is required to stabilize PINK1 on the outside of mitochondria to initiate mitophagy upon membrane depolarization.
Journal ArticleDOI
Molecular targets and approaches to restore autophagy and lysosomal capacity in neurodegenerative disorders.
TL;DR: In this article, the authors conceptualized mechanistic and genetic evidence pointing towards autophagy and lysosomal dysfunction as a causal driver of neurodegeneration and discussed rate-limiting pathway nodes and potential approaches to restore pathway activity.